[Introduction. Rilpivirine]

Enferm Infecc Microbiol Clin. 2013 Jun:31 Suppl 2:1. doi: 10.1016/S0213-005X(13)70135-6.

[Article in Spanish]

Author

Daniel Podzamczer¹

Affiliation

¹ Director del Programa VIH/SIDA, Unidad VIH, Servicio de Enfermedades Infecciosas, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España. Electronic address: dpodzamczer@bellvitgehospital.cat.

PMID: 24252526
DOI: 10.1016/S0213-005X(13)70135-6

No abstract available

Publication types

Introductory Journal Article

MeSH terms

Anti-HIV Agents / administration & dosage
Anti-HIV Agents / pharmacokinetics
Anti-HIV Agents / therapeutic use*
Antiretroviral Therapy, Highly Active
Drug Therapy, Combination
HIV Infections / drug therapy
Humans
Nitriles / administration & dosage
Nitriles / pharmacokinetics
Nitriles / therapeutic use*
Pyrimidines / administration & dosage
Pyrimidines / pharmacokinetics
Pyrimidines / therapeutic use*
Reverse Transcriptase Inhibitors / administration & dosage
Reverse Transcriptase Inhibitors / pharmacokinetics
Reverse Transcriptase Inhibitors / therapeutic use*
Rilpivirine

Substances

Anti-HIV Agents
Nitriles
Pyrimidines
Reverse Transcriptase Inhibitors
Rilpivirine